Gilead Sciences (GILD)
Gilead hit a grand slam with the release of its new blockbuster HEP-C drugs,
Sovaldi and Harvoni. These new drugs were the catalyst for Gileads
antiviral product growth, robust revenue growth, sales
by Ronald N. Kahn, Manager, Special
We all know how to torture the data until it
In an uncertain world, results aren't always
what they appear.